At a glance
- Originator Takeda
- Developer Nonindustrial source; Takeda
- Class Antiulcers; Gastrokinetics
- Mechanism of Action Motilin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Gastritis; Gastro-oesophageal reflux
Most Recent Events
- 10 Oct 2000 Discontinued-II for Gastritis in Japan (PO)
- 10 Oct 2000 Discontinued-II for Gastro-oesophageal reflux in USA (PO)
- 12 Jun 2000 Profile reviewed but no significant changes made